Abstract:The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) is a crucial innate defence mechanism against viral infection in the innate immune system, as it principally induces the production of type I interferons. Immune responses and metabolic control are inextricably linked, and chronic low-grade inflammation promotes the development of metabolic diseases. The cGAS-STING pathway activated by double-stranded DNA (dsDNA), cyclic dinucleotides (CDNs), endoplasmic reticulum stress (ER stress), mitochondrial stress, and energy imbalance in metabolic cells and immune cells triggers proinflammatory responses and metabolic disorders. Abnormal overactivation of the pathway is closely associated with metabolic diseases such as obesity, nonalcoholic fatty liver disease (NAFLD), insulin resistance and cardiovascular diseases (CVDs). The interaction of cGAS-STING with other pathways, such as the nuclear factor-kappa B (NF-κB), Jun N-terminal kinase (JNK), AMP-activated protein kinase (AMPK), mammalian target of rapamycin (mTOR), autophagy, pyroptosis and insulin signalling pathways, is considered an important mechanism by which cGAS-STING regulates inflammation and metabolism. This review focuses on the link between immune responses related to the cGAS-STING pathway and metabolic diseases and cGAS-STING interaction with other pathways for mediating signal input and affecting output. Moreover, potential inhibitors of the cGAS-STING pathway and therapeutic prospects against metabolic diseases are discussed. This review provides a comprehensive perspective on the involvement of STING in immune-related metabolic diseases.

The role of the cGAS-STING pathway in metabolic diseases

cGAS-STING signaling pathway in gastrointestinal inflammatory disease and cancers

The Role of cGAS-STING Signalling in Metabolic Diseases: from Signalling Networks to Targeted Intervention

Cellular functions of cGAS-STING signaling

Lysosomal Control of the Cgas-Sting Signaling.

The cGAS–STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy

The Cgas-Sting Pathway: Post-translational Modifications and Functional Implications in Diseases

Cgas/sting: Novel Perspectives of the Classic Pathway

The Role of cGAS-STING in Age-Related Diseases from Mechanisms to Therapies

The cGAS-STING pathway in cardiovascular diseases: from basic research to clinical perspectives

Significance of the cGAS-STING Pathway in Health and Disease

The effects of cGAS-STING inhibition in liver disease, kidney disease, and cellular senescence

Current understanding of the cGAS-STING signaling pathway: Structure, regulatory mechanisms, and related diseases

cGAS-STING signaling in cardiovascular diseases

Research Advances in How the cGAS-STING Pathway Controls the Cellular Inflammatory Response

Cgas–sting, an Important Signaling Pathway in Diseases and Their Therapy

The triggers of the cGAS-STING pathway and the connection with inflammatory and autoimmune diseases

The role of the cGAS-STING signaling pathway in viral infections, inflammatory and autoimmune diseases

cGAS/STING signalling pathway in senescence and oncogenesis

Advances in structure-guided mechanisms impacting on the cGAS-STING innate immune pathway

The cGAS–STING pathway as a therapeutic target in inflammatory diseases